{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T21:09:51Z","timestamp":1779224991412,"version":"3.51.4"},"reference-count":10,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2007,4,13]],"date-time":"2007-04-13T00:00:00Z","timestamp":1176422400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsia"],"published-print":{"date-parts":[[2007,7]]},"abstract":"<jats:p><jats:bold>Summary:\u2002<\/jats:bold>  <jats:italic>Purpose:<\/jats:italic> Gaucher disease (GD) is an autosomal recessive lysosomal disorder caused by a deficiency of glucocerebrosidase. The neurologic manifestations of GD patients have to date been refractory to any treatment approach. We present a report of a neuronopathic GD patient whose myoclonic epilepsy improved after combination therapy with imiglucerase and miglustat.<\/jats:p><jats:p> <jats:italic>Methods:<\/jats:italic> In an adult type 3 GD patient who, despite good visceral and analytic response to ERT, developed progressive neurologic deterioration with marked myoclonic epilepsy and dystonia, we added miglustat to the enzyme\u2010replacement therapy.<\/jats:p><jats:p> <jats:italic>Results:<\/jats:italic> After 2 years of combined miglustat (200 mg, 3 t.i.d.) and imiglucerase (60 IU\/kg every 2 weeks), generalized tonic\u2013clonic seizures decreased, speech improved, and the general neurologic clinical picture improved markedly. The EEG showed a reduction in focal and generalized paroxysmal discharges. No significant adverse effects were observed.<\/jats:p><jats:p> <jats:italic>Conclusions:<\/jats:italic> Combined imiglucerase and miglustat therapy may be beneficial for some neuronopathic forms of GD.<\/jats:p>","DOI":"10.1111\/j.1528-1167.2007.01074.x","type":"journal-article","created":{"date-parts":[[2007,4,18]],"date-time":"2007-04-18T16:52:11Z","timestamp":1176915131000},"page":"1406-1408","source":"Crossref","is-referenced-by-count":49,"title":["Neurologic Improvement in a Type 3 Gaucher Disease Patient Treated with Imiglucerase\/Miglustat Combination"],"prefix":"10.1111","volume":"48","author":[{"given":"Jose L.","family":"Capablo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Franco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia S\u00e1enz","family":"De Cabez\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Alfonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Pocovi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Giraldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,4,13]]},"reference":[{"key":"e_1_2_4_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2005.05.007"},{"key":"e_1_2_4_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199105233242104"},{"key":"e_1_2_4_4_1","doi-asserted-by":"crossref","unstructured":"FutermanAH.(2006)Intracellular trafficking of sphingolipids: relationship to biosynthesisBiochimica et Biophysica Acta. Aug 15 on line.","DOI":"10.1016\/j.bbamem.2006.08.004"},{"key":"e_1_2_4_5_1","first-page":"125","article-title":"Short term effect in an every day clinical use of miglustat in na\u00efve or previously treated type 1 Gaucher disease","volume":"91","author":"Giraldo P","year":"2006","journal-title":"Haematologica"},{"key":"e_1_2_4_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-004-0794-y"},{"key":"e_1_2_4_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/humu.20217"},{"key":"e_1_2_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2004.09.004"},{"key":"e_1_2_4_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.57.3.389"},{"key":"e_1_2_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2004.04.011"},{"key":"e_1_2_4_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-006-0239-6"}],"container-title":["Epilepsia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1528-1167.2007.01074.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1528-1167.2007.01074.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T08:12:10Z","timestamp":1697098330000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1528-1167.2007.01074.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,13]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["10.1111\/j.1528-1167.2007.01074.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1528-1167.2007.01074.x","archive":["Portico"],"relation":{},"ISSN":["0013-9580","1528-1167"],"issn-type":[{"value":"0013-9580","type":"print"},{"value":"1528-1167","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,13]]}}}